Sequentify hosted a MasterClass titled Learn to Think Like a Board Member: Case Study Board Simulations on October 5, 1:30-5:00 PM at the Private Directors Association® Annual Conference PRISM 2026 with Naomi Kent, Israel Rollins, NACD.DC., and Valerie Darling.
Published
Signal category
Presence & Recognition
Quote
“Excited about our MasterClass “Learn to Think Like a Board Member: Case Study Board Simulations” on October 5, 1:30-5:00 PM at the Atlanta Grand Hyatt Buckhead at the Private Directors Association® Annual Conference PRISM 2026 with Naomi Kent, Israel Rollins, NACD.DC., and me.”
— Valerie Darling|Sequentify team
Company
Sequentify
Make targeted sequencing as common and affordable as a blood test.
- Industry
- Biotechnology
- Location
- Rehovot, IL
- Company size
- 7 employees
At Sequentify, we empower genomic labs to achieve scalable, population-wide genomic sequencing through our innovative solutions. Our technology is designed to decentralize genomic testing by addressing the industry's top three challenges: sample preparation, result analysis, and cost reduction. Our end-to-end solution offers unmatched scalability, automation friendliness, and cost-effectiveness, making it ideal for diverse applications, including cancer diagnostics, carrier screening, and infectious disease. Currently raising our Series A round, as we aim to accelerate growth.
Founded 2021